Literature DB >> 22020027

Moyamoya disease in China: its clinical features and outcomes.

Lian Duan1, Xiang-Yang Bao, Wei-Zhong Yang, Wan-Chao Shi, De-Sheng Li, Zheng-Shan Zhang, Rui Zong, Cong Han, Feng Zhao, Jie Feng.   

Abstract

BACKGROUND AND
PURPOSE: Here we describe the clinical features and outcomes of patients with moyamoya disease who were surgically treated at a single institution in China.
METHODS: Our cohort included 802 patients with moyamoya disease. Demographic and clinical characteristics were obtained by retrospective chart review; follow-up information and outcome were obtained through clinical visits, telephone, or letter interview. We used the Kaplan-Meier methods to estimate stroke risk by treatment status.
RESULTS: The median age for the onset of symptoms was 28 (range, 0.5-77) years. Two definite peaks in age distribution were found. The ratio of women to men was 1:1 (398/404). Familial occurrence of moyamoya disease was 5.2%. The initial symptom was ischemia, hemorrhage, or others in 564, 113, and 125 patients, respectively. Twenty-nine of the 802 patients (3.6%) received conservative management. The remaining 773 patients (96.4%) underwent neurosurgical revascularization procedures, and 502 of these were bilateral. The median follow-up after surgery (n=773) or conservative management (n=26) was 26.3 months (range, 6.0-101.9 months). Most subsequent ischemic events appeared in the first 2 years after surgery. The Kaplan-Meier estimated stroke risk was 10.1% in the first 2 years, and the 5-year-Kaplan-Meier risk of stroke was 12.7% after surgery for all patients treated with surgical revascularization.
CONCLUSIONS: This study on the clinical features of moyamoya disease in mainland China indicated bimodal incidence distribution with women-to-men ratios of 1:1 and lower rate of hemorrhages in adults compared with in children. Patients had low rates of postoperative ischemic or hemorrhagic strokes, and the majority of patients had preserved functional status after revascularization.

Entities:  

Mesh:

Year:  2011        PMID: 22020027     DOI: 10.1161/STROKEAHA.111.621300

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  43 in total

1.  Treatment course and outcomes after revascularization surgery for moyamoya disease in adults.

Authors:  Amanda Kahn; Gurmeen Kaur; Laura Stein; Stanley Tuhrim; Mandip S Dhamoon
Journal:  J Neurol       Date:  2018-09-08       Impact factor: 4.849

2.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

Review 3.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

4.  Moyamoya syndrome causing stroke in young women with type 1 diabetes.

Authors:  Jing W Hughes; Jennifer A Wyckoff; Abby S Hollander; Colin P Derdeyn; Janet B McGill
Journal:  J Diabetes Complications       Date:  2016-08-12       Impact factor: 2.852

Review 5.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

6.  Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.

Authors:  Xiang Guo; Xuexia Yuan; Lingyun Gao; Yueqin Chen; Hao Yu; Weijian Chen; Yunjun Yang; Zhen Chong; Zhanguo Sun; Feng Jin; Deguo Liu
Journal:  Eur Radiol       Date:  2021-05-06       Impact factor: 5.315

Review 7.  The growing problem of stroke among young adults.

Authors:  Sally Sultan; Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 8.  Basal and Acetazolamide Brain Perfusion SPECT in Internal Carotid Artery Stenosis.

Authors:  Teck Huat Wong; Qaid Ahmed Shagera; Hyun Gee Ryoo; Seunggyun Ha; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-01-08

9.  Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China.

Authors:  Fei Ye; Tianzhu Wang; Haoyuan Yin; Jiaoxing Li; Haiyan Li; Tongli Guo; Xiong Zhang; Tingting Yang; Liang Jie; Xiaoxin Wu; Qi Li; Wenli Sheng
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

10.  Clinical Significance of Ultrasound-Based Hemodynamic Assessment of Extracranial Internal Carotid Artery and Posterior Cerebral Artery in Symptomatic and Angiographic Evolution of Moyamoya Disease: A Preliminary Study.

Authors:  Shuai Zheng; Peicong Ge; Zhiyong Shi; Jingzhe Wang; Yi Li; Tengfei Yu; Jinghan Zhang; Hongxia Zhang; Dong Zhang; Wen He
Journal:  Front Neurol       Date:  2021-05-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.